Divi's Laboratories inks manufacturing and supply agreement with global pharma company
The company expects meaningful revenue contribution from this long-term agreement
The company expects meaningful revenue contribution from this long-term agreement
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Net Profit increased by 15% to Rs. 146 crores in Q4 FY25 and 19% to Rs. 660 crores in FY25
The CDMO upgrade represents a transformational step for Remedium Lifecare
Standalone profit from operations for the quarter were Rs. 162 crores
EBITDA before special items decreases to €4.08 billion (7.4%)
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
These observations are procedural in nature and none of them are related to data integrity
Investment demonstrates confidence in America’s commitment to science and innovation
Subscribe To Our Newsletter & Stay Updated